STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices
Reported by STAT News · all stories from statnews.com
Editorial digest
This report covers an investigation into Commure, alongside an examination of Medicare's new technology incentives for AI-powered devices. The focus is on how these incentives are shaping the health tech landscape.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/13/2026
STAT+: What Medicare incentives for AI-based devices mean for tech companies — and hospitals
Medicare incentives for AI-based devices affect tech companies and hospitals.
- Trusted health newsroom9/15/2026
STAT+: Medicare’s AI prior authorization pilot was rushed and full of problems, new documents reveal
Medicare's AI prior authorization program faced issues and was launched too quickly, according to new details.
- Trusted health newsroom9/2/2026
STAT+: How a former ARPA-H director’s startup is tackling AI’s ‘dumb problems’
A startup led by a former ARPA-H director is addressing common AI challenges.
- Trusted health newsroom8/25/2026
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
The FDA will issue new AI regulations; Epic's user meeting also had significant updates.
- Trusted health newsroom8/6/2026
STAT+: Medicare pushes ACCESS but doesn’t tell patients what providers offer it
Medicare is promoting a program but not informing patients about participating providers.
- Trusted health newsroom8/26/2026
STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
Daphne Koller from Insitro discusses using artificial intelligence to accelerate clinical studies.